eScholarship
metadata only
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage
BACKGROUND: Measuring plasma glial fibrillary acidic protein (GFAP) alongside cortical amyloid-β (Aβ) may shed light on astrocytic changes in aging and Alzheimer's disease (AD). OBJECTIVE: To examine associations between plasma GFAP and cortical Aβ deposition in older adults across the typical aging
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The role of glial fibrillary acidic protein (GFAP) in astrocyte and central nervous system (CNS) dysfunction#672801
- Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories#1174829
- Patient-reported outcomes - the missing link to advancing light chain (AL) amyloidosis clinical research.#209461
- Microbiota-Gut-Brain Axis in Neurodegenerative Diseases: The Role of Bacterial Amyloids#471980
- Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome#1145674
Record · ID 1133044
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive